论文部分内容阅读
近20年来对组织学上和临床上界于良恶之间的卵巢上皮性肿瘤的诊断及治疗已引起关注.发现这类肿瘤预后比恶性肿瘤好,细胞成份上与恶性也有明确不同,年轻人多见.其主要疗法是手术.化疗和放疗文献中尚未见充分讨论.为了确定化疗和放疗辅助治疗的作用,收集马萨诸塞总医院1962年至1979年期间675例卵巢癌,进行了复习.资料齐全的所有上皮性交界性肿瘤都列入:粘液性25例;浆液性36例和子宫内膜样1例,共62例.组织学分类根据FIGO和WHO规定.切片由同一位病理学家复习.根据FIGO规定、手术记录和病理报告而定期别.病史、临床症状、随访情况及详细疗法均作了小结.8%卵巢粘液性交界性囊腺瘤(以下皆称粘液性瘤)和12%卵巢浆液性交界性囊腺瘤(以下皆称浆液性瘤)是复发病例,因无法估计原期别而在存活率计算中未计入.
Nearly 20 years of histological and clinical community between the benign and malignant epithelial ovarian cancer diagnosis and treatment has attracted attention and found that such cancer prognosis than malignant, cell composition and malignant also have a clear difference, young people The main treatment is surgery.Chemotherapy and radiotherapy literature has not been fully discussed.In order to determine the role of chemotherapy and radiotherapy adjuvant therapy, the General Hospital of Massachusetts collected from 1962 to 1979, 675 cases of ovarian cancer, were reviewed. Of all epithelial borderline tumors were included: mucinous in 25 cases, serous in 36 cases and endometrial-like in 1 case, a total of 62. Histological classification according to FIGO and WHO regulations. Slice by the same pathologist review. According to FIGO regulations, surgical records and pathological reports on a regular basis, history, clinical symptoms, follow-up and detailed treatment were summarized.8% of ovarian mucinous borderline cystadenoma (hereinafter referred to as myxoma) and 12% of ovaries Serous borderline cystadenocarcinoma (hereinafter referred to as serous tumor) is a recurrence of cases, because the original date can not be estimated in the calculation of survival rate not included.